Is ResMed Stock Outperforming the Dow?

With a market cap of $32.6 billion, San Diego, California-based ResMed Inc. (RMD) is a global leader in designing, manufacturing, and distributing medical devices and cloud-based software solutions for sleep-disordered breathing (SDB) and other respiratory conditions. It serves sleep clinics, home healthcare providers, and hospitals worldwide, helping improve patient outcomes and healthcare efficiency.

Companies valued at $10 billion or more are generally classified as “large-cap” stocks, and ResMed fits this criterion perfectly. The company operates through two segments - Sleep and Respiratory Care and Software-as-a-Service, offering a wide range of products, including diagnostic devices, connected care solutions, and out-of-hospital software platforms.